United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded May 21, 2026 · Filed May 22, 2026

On May 21, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$564.11 for US$5.36M under a trading plan, leaving 40,513 shares. Filed May 22, 2026 (Form 4).

Sold
9,500 shares
Price
US$564.11 average (US$557.85 to US$566.42)
Value
US$5.36M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 21, 2026Common StockOption exercise9,500US$146.0350,013Direct
May 21, 2026Common StockSale40US$557.8549,973Direct
May 21, 2026Common StockSale280US$560.0349,693Direct
May 21, 2026Common StockSale919US$561.9748,774Direct
May 21, 2026Common StockSale1,760US$562.9847,014Direct
May 21, 2026Common StockSale2,242US$563.7744,772Direct
May 21, 2026Common StockSale1,840US$564.8742,932Direct
May 21, 2026Common StockSale2,259US$566.0240,673Direct
May 21, 2026Common StockSale160US$566.4240,513Direct

Source

View original at SEC

Related